Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Up 127.5% in June

Revolution Medicines, Inc. (NASDAQ:RVMDW) saw a significant growth in short interest in the month of June. As of June 30th, there was short interest totaling 3,115 shares, a growth of 127.5% from the June 15th total of 1,369 shares. Based on an average trading volume of 95,598 shares, the short-interest ratio is presently 0.0 days.

Revolution Medicines Trading Down 7.2%

Shares of Revolution Medicines stock traded down $0.65 during trading on Thursday, reaching $8.42. The company’s stock had a trading volume of 25,860 shares, compared to its average volume of 127,589. The business’s fifty day moving average price is $6.95 and its 200-day moving average price is $4.02. Revolution Medicines has a one year low of $0.16 and a one year high of $10.12.

About Revolution Medicines

Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.

Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.